ASLAN Pharmaceuticals Limited Banner Image

ASLAN Pharmaceuticals Limited

  • Ticker ASLN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
ASLAN Pharmaceuticals Limited Logo Image
  • 51-200 Employees
  • Based in Singapore, Singapore
ASLAN Pharmaceuticals (ASLAN, 6497.TT) is a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets. ASLAN targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Led by a senior management team with extensive experience in global and regional development and commercialization, ASLANMore is headquartered in Singapore and has offices in Taiwan and China. ASLAN’s portfolio is comprised of four product candidates which target validated growth pathways applied to new patient segments, novel immune checkpoints and novel cancer metabolic pathways. ASLAN’s partners include Array BioPharma, Bristol-Myers Squibb, Almirall and CSL.
4.7 / 5.0 (96)

ASLAN Pharmaceuticals Limited reports have an aggregate usefulness score of 4.7 based on 96 reviews.

ASLAN Pharmaceuticals Limited

Most Recent Annual Report

ASLAN Pharmaceuticals Limited
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

ASLAN Pharmaceuticals Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!